Skip to content

Clinical trials

Phase 3 Obesity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Clear all

488 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20018
20025
20038
200413
200510
200625
200722
200816
200911
20108
201120
201214
201313
20149
20156
201615
201710
201814
201911
20206
202118
202220
202331
202423
202546
202685

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed261
Recruiting73
Active, not recruiting38
Unknown status35
Not yet recruiting35
Terminated35
Withdrawn9
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S61
Eli Lilly and Company48
Sanofi18
Pfizer13
Amgen11
Boehringer Ingelheim10
Hoffmann-La Roche7
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.7
Abbott6
Merck Sharp & Dohme LLC6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity488
Overweight172
Diabetes Mellitus, Type 266
Weight Loss40
Diabetes Mellitus26
Hypertension23
Nutrition Disorders22
Insulin Resistance20
Sleep Apnea, Obstructive19
Cardiovascular Diseases18

Trials

Showing 51 to 75 of 488. Each trial links to its page on Pharma Observatory.

388 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.